Po14
To explore the preliminary experience of the seeds activity and dosage selection of personalized iodine-125 seeds interstitial brachytherapy (PISI-BT) for paraintestinal metastasis of gynecological squamous cell carcinoma (SCC). (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Juan Wang, Yansong Liang, Hongtao Zhang, Jinxin Zhao Source Type: research
Po15
To explore the factors influencing the short-term efficacy of 125I seed implantation in the treatment of perivascular lymph node metastasis of cervical cancer after radiotherapy and chemotherapy. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Ke Xu Source Type: research
Po16
To evaluate the relationship of dosimetry parameters and efficacy of 3D-printing template assisted 125I seeds implantation for recurrent cervical cancer (RCC). (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: JUAN WANG, Jinxin zhao, Yansong Liang, Ke Xu Source Type: research
Po17
To investigate the relationship between dose parameters and tumor volume reduction ratio after 125I seed implantation for recurrent cervical squamous cell carcinoma, and to obtain the better parameters to predict the curative effect. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Juan Wang, Jinxin Zhao, Yansong Liang, Huiming Yu Source Type: research
Po18
To investigate when an MR-compatible multi-channel (MC) interstitial cylinder can serve as a substitute for Syed-based interstitial (IS) HDR brachytherapy using titanium needles for cancers within the gynecologic tract. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Hania Al-Hallaq, Tianming Wu, Yasmin Hasan Source Type: research
Po19
The rise of image guided adaptive brachytherapy (IGABT) in combination with advances in inverse optimization tools has led to improved plan quality via utilization of rich 3D patient-specific anatomical information. The necessity to generate directional “anisotropic” radiation beam for better conformance of dose distributions to target volumes while integrating seamlessly into existing IGABT clinical workflows is apparent. The novel MR-compatible Direction Modulated Brachytherapy (DMBT) tandem applicator accomplishes this by using a six-periphe ral-source-channel design. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Dylan Richeson, Somayeh Gholami, Binod Manandhar, Sharmin Alam, Suman Gautam, Daniel Scanderbeg, Catheryn Yashar, Joann Prisciandaro, Shruti Jolly, Emma Fields, William Y Song Source Type: research
Po20
Over the past few years, the complexity of brachytherapy (BT) has increased and the practice patterns have shifted to distinguish high-volume centers as primary sites for these procedures. As a result, women with locally advanced cervical cancer (LACC) who are treated with external-beam radiotherapy (EBRT) at local centers, are now more likely to be referred to higher-volume centers for their final BT boost. In previous publications, the American Brachytherapy Society found that patients at high-volume centers are more likely to receive higher-quality care. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Nophar Yarden, Catherine Sport, Nitai Mukhopadhyay, Emma C. Fields Source Type: research
Po21
Brachytherapy (BT) has been utilized for the treatment of anal cancer for many decades. A previous systematic review had shown benefit of BT boost in patients undergoing curative intent chemo-radiotherapy for anal canal cancer. Despite this, the use of BT boost is still restricted to a few chosen institutions and is typically not mentioned as a therapeutic alternative in the well-known international standards. Barriers to its widespread implementation have been identified as specialised knowledge, complexity, and equipment. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Alvin Kumar, Avtar Raina Source Type: research
Po22
There are few studies on the operation time of gynecologic brachytherapy. We retrospectively analyzed the detailed operation time of image-guided brachytherapy (IGBT) for patients with gynecologic malignancies at our institution. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Yoshiaki Takagawa, Masanori Machida, Ichiro Seto, Shinya Komori, Hiroki Sato, Hiroko Midorikawa, Masao Murakami Source Type: research
Po23
Optimally placing interstitial needles for hybrid intracavitary/interstitial (IC/IS) gynecologic brachytherapy requires time and expertise. Previously reported 3D-printed templates (TARGIT and TARGIT-FX, Tandem Anchored Radially Guided Interstitial Templates, Flexible and eXtended) guide needles to dosimetrically beneficial positions, which simplifies procedures, decreases procedure time, improves needle distribution and optimizes dosimetry. A subset of patients with extreme or unique tumor topologies required needle positions outside of the standard TARGIT-FX options. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Thomas Niedermayr, Elizabeth Kidd Source Type: research
Po24
To evaluate the dosimetric impact of bladder fill change between the time of simulation and treatment delivery. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Marc Morcos, James McCulloch, Gabi Quintana, Marco Martinez, Mayra Gonzalez-Ng, Yonatan Weiss Source Type: research
Po25
To investigate the clinical utility of inverse optimization for developing time-constrained treatment plans for patients with cancers in the gynecologic tract undergoing HDR interstitial brachytherapy. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Hania Al-Hallaq, Tianming Wu, Yasmin Hasan Source Type: research
Po26
Radiation toxicity to female erectile tissue, specifically the bulboclitoral apparatus, has not been previously investigated. This retrospective cohort study aims to demonstrate the feasibility of contouring the bulboclitoris (BC) and evaluate dose received by the BC in patients who underwent interstitial gynecologic brachytherapy for tumors involving the lower vagina and periurethral region. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Pooja Venkatesh, Juhi Purswani, Nicholas Colangelo, Sofia Perez Otero, Nicole Hindman, Stella Lymberis Source Type: research
Po27
This study aims to investigate the dosimetric impact of false reconstruction of abutting needles. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Kai Jiang, Naru Lamichhane, Elizabeth Nichols, Shifeng Chen, Byongyong Yi, Pranshu Mohindra Source Type: research
Po28
Patient safety, workflow efficiency, and adhering to time constraints are imperative challenges in brachytherapy treatment. A novel mobile cone beam computed tomography (CBCT) imaging device (IRm, Elekta, Veenendaal, Netherlands), recently adopted for brachytherapy, can effectively improve these difficulties. Its compact size and mobility offer a safe, efficient, and quick method for imaging gynecological cases. This is the first study investigating the image quality and workflow required for GYN brachytherapy employing the mobile imaging ring. (Source: Brachytherapy)
Source: Brachytherapy - September 1, 2023 Category: Cancer & Oncology Authors: Cullen Boyle, Firas Mourtada, Dorin Todor, Rani Anne, Emma Fields, Reza Taleei Source Type: research
